Carson Wealth (CWM LLC)
MIRM icon

Carson Wealth (CWM LLC)’s Mirum Pharmaceuticals MIRM Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$76.7K Buy
830
+150
+22% +$14.1K ﹤0.01% 3483
2025
Q4 		$54K Sell
680
-3
-0.4% -$215 ﹤0.01% 3549
2025
Q3 		$50K Buy
683
+161
+31% +$10.2K ﹤0.01% 3537
2025
Q2 		$27K Sell
522
-71
-12% -$3.16K ﹤0.01% 3713
2025
Q1 		$27K Buy
593
+428
+259% +$20.2K ﹤0.01% 3467
2024
Q4 		$7K Buy
165
+43
+35% +$1.79K ﹤0.01% 4059
2024
Q3 		$5K Buy
122
+74
+154% +$2.95K ﹤0.01% 4111
2024
Q2 		$2K Buy
48
+40
+500% +$1.05K ﹤0.01% 4235
2024
Q1 		$0 Buy
+8
New +$220 ﹤0.01% 4568
2023
Q3 		– Sell
-199
Closed -$5K – 4389
2023
Q2 		$5K Buy
+199
New +$5.29K ﹤0.01% 3451
2022
Q4 		– Sell
-42
Closed -$1K – 4140
2022
Q3 		$1K Hold
42
– – ﹤0.01% 3697
2022
Q2 		$1K Hold
42
– – ﹤0.01% 3577
2022
Q1 		$1K Buy
+42
New +$857 ﹤0.01% 3375

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Carson Wealth (CWM LLC)'s MIRM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Mirum Pharmaceuticals (MIRM) stake by 22% in Q1 2026, buying an estimated $14.1K and bringing the position to 830 shares worth $76.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3483.

Carson Wealth (CWM LLC) first reported a position in MIRM in Q1 2022 and has held it in 13 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 830 shares of Mirum Pharmaceuticals worth $76.7K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 150 Mirum Pharmaceuticals shares in Q1 2026, an estimated $14.1K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3483 holding.
  • Carson Wealth (CWM LLC) first reported a position in Mirum Pharmaceuticals in Q1 2022 and has held it in 13 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.